Brandtree

Who owns Epocler?

Epocler is owned by Hypera (Brazil, B3: HYPE3).[1]

This ownership is reported in official statements but has not yet been matched to a regulatory filing.

Key facts

Current owner
Hypera Pharma reported
Owned since
Not recorded
Previous owner
None recorded
Owner HQ
🇧🇷 Brazil, São Paulo
Origin
🇧🇷 Brazil
Category
Consumer healthOver-the-counter medicineDigestive health
Parent ticker
B3: HYPE3
Last verified
· 1 sources

About Epocler

Epocler is a Hypera Pharma liver remedy sold as tablets and as 10 ml drinkable vials, including a strawberry flavour. The company says it helps treat metabolic liver disorders by aiding fat metabolism, reducing fat build-up in the liver and helping remove metabolic waste, and warns that it is not meant to prevent liver problems.

Ownership timeline of Epocler

  1. ? – present Hypera [1] reported

Where Epocler sits in Hypera

Controlling ownership as of . Brands grouped under the entity that owns them; large groups are collapsed.

Where Epocler sits in Hypera Tree of 8 brands under Hypera. Hypera Epocler Benegrip Biotônico Fontoura Doril Engov Estomazil and 2 more

Open the full Hypera ownership tree →

Other brands owned by Hypera in consumer health

See the full Hypera brand portfolio (8) →

Latest news about Epocler

No tagged news items yet. Deals, regulatory actions and recalls are added from SEC filings, regulators and trade press; only titles and links are stored.

Headlines link to the original publisher. Brandtree does not reproduce article text.

Frequently asked questions

Who is the parent company of Epocler?

The parent company of Epocler is Hypera, a publicly listed company headquartered in Brazil.

Is Epocler Brazilian?

Yes. Epocler originated in Brazil and its owner, Hypera, is also headquartered in Brazil.

Is Epocler still owned by Hypera?

Yes. As of 16 September 2026, Epocler is still owned by Hypera. The ownership record was last checked against primary sources on that date.

Sources (1) & corrections

Last verified . Every ownership fact above is backed by one of these primary documents. Numbers in brackets in the text refer to this list.

  1. [1] Hypera Pharma — Corporate Profile (investor relations, updated 18 June 2026) — Hypera Pharma, Official document, published 18 June 2026; retrieved 16 September 2026.

Report a correction Opens a pre-filled GitHub issue. See our corrections policy.